The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.
D000249:Adenosine Monophosphate / Q000378:metabolism; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004727:Endothelium / Q000187:drug effects / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007930:Leucine / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D016686:Monocrotaline / Q000031:analogs & derivatives; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D010947:Plants, Toxic; D011758:Pyrroles / Q000378:metabolism / Q000494:pharmacology*; D011763:Pyrrolizidine Alkaloids / Q000494:pharmacology*; D051381:Rats; D012674:Senecio; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution
D011758:Pyrroles; D011763:Pyrrolizidine Alkaloids; D012701:Serotonin; D000249:Adenosine Monophosphate; D016686:Monocrotaline; D007930:Leucine; C007241:dehydroretronecine; D009638:Norepinephrine